 |
SpliceBio
Last updated: October 11, 2024
Miquel VilaPerelló, CEO
Spain | Funding: $58.8M (+)
Website: https://splice.bio/
Splice Bio is a biotech company developing gene therapies based on a platform that could bypass the cargo capacity of adeno-associated vectors (AAVs).
Website: https://splice.bio/
Splice Bio is a biotech company developing gene therapies based on a platform that could bypass the cargo capacity of adeno-associated vectors (AAVs).
